I don't know what's going on here
This is our new house
Maybe we only had one chair
If you read these things you will know that I have immense
enthusiasm for immunotherapy in general, but am pessimistic about the pace with
which it is being applied to solid tumors, and specifically OVCA. Well, these two articles signal hope just
over the horizon. It appears that French
and a Japanese research outfits have made significant progress on applying immunotherapeutic techniques to ovarian
cancer – in mice. The method requires
sequencing the tumor’s genome, then devising an individualized drug to croak it. HOW this works remains several notches above
my pay grade, but the FDA seems to be smiling upon it so there is reason for optimism. A Phase 1 trial is in the offing.
No comments:
Post a Comment